CHEMED CORP (CHE) Forecast, Price Target & Analyst Ratings
NYSE:CHE • US16359R1032
412.855 USD
+1.87 (+0.45%)
Last: Mar 5, 2026, 03:34 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CHEMED CORP (CHE).
Forecast Snapshot
Consensus Price Target
$566.61
+ 37.24% Upside
Next Earnings Forecast
Release DateApr 21, 2026
PeriodQ1 / 2026
EPS Estimate$5.57
Revenue Estimate658.51M
ChartMill Buy Consensus
75.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$566.61
Upside
+ 37.24%
From current price of $412.86 to mean target of $566.61, Based on 8 analyst forecasts
Low
$479.75
Median
$587.52
High
$624.75
Price Target Revisions
1 Month
-3.27%
3 Months
-3.27%
Price Target Summary
8 analysts have analysed CHE and the average price target is 566.61 USD. This implies a price increase of 37.24% is expected in the next year compared to the current price of 412.855.
The average price target has been revised downward by 3.27% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
75.00%
CHE was analyzed by 8 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about CHE.
In the last month the buy percentage fell by 8 points. So the trust of analysts is decreasing.
CHE was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-27 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2026-02-27 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2026-01-22 | Jefferies | Downgrade | Buy -> Hold |
| 2025-11-10 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-09-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-09-02 | Jefferies | Upgrade | Hold -> Buy |
| 2025-07-31 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-07-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-25 | Jefferies | Initiate | Hold |
| 2025-06-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-30 | B of A Securities | Maintains | Buy -> Buy |
| 2025-04-28 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-03-14 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-05-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-03-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-29 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-01-17 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-10-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-07-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-07-27 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-05-01 | RBC Capital | Maintains | Outperform |
| 2023-04-28 | Oppenheimer | Maintains | Outperform |
| 2023-02-27 | RBC Capital | Maintains | Outperform |
| 2022-11-03 | RBC Capital | Maintains | Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 21, 2026
PeriodQ1 / 2026
EPS Estimate$5.57
Revenue Estimate658.51M
Revenue Q2Q1.79%
EPS Q2Q-1.02%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
CHE is expected to report earnings on 4/21/2026. The consensus EPS estimate for the next earnings is 5.57 USD and the consensus revenue estimate is 658.51M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.264B 6.06% | 2.431B 7.37% | 2.53B 4.06% | 2.697B 6.60% | 2.863B 6.15% | 3.032B 5.90% | |
| EBITDA YoY % growth | 421.788M 4.35% | 470.279M 11.50% | 422.171M -10.23% | 499.62M 18.35% | 545.66M 9.22% | 583.28M 6.89% | |
| EBIT YoY % growth | 360.923M 4.62% | 407.23M 12.83% | 357.33M -12.25% | 447.32M 25.18% | 494.35M 10.51% | 540.48M 9.33% | |
| Operating Margin | 15.94% | 16.75% | 14.12% | 16.59% | 17.27% | 17.83% | |
| EPS YoY % growth | 21.45 8.55% | 23.14 7.88% | 21.59 -6.70% | 24.25 12.32% | 27.10 11.76% | 29.19 7.71% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 5.57 -1.02% | 5.45 27.55% | 6.17 17.16% | 7.09 10.44% |
| Revenue Q2Q % growth | 658.51M 1.79% | 666.68M 7.74% | 676.98M 8.33% | 705.02M 10.27% |
| EBITDA Q2Q % growth | 116.49M 3.45% | 114.11M 11.73% | 124.41M -4.11% | 146.75M -14.47% |
| EBIT Q2Q % growth | 97.835M 1.29% | 95.009M 36.01% | 105.59M 29.98% | 132.38M 24.02% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
10.57%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
5.60%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
13.68%
EBIT Next 5 Year
N/A
CHEMED CORP / CHE Forecast FAQ
What is the price target for CHE stock?
8 analysts have analysed CHE and the average price target is 566.61 USD. This implies a price increase of 37.24% is expected in the next year compared to the current price of 412.855.
When does CHEMED CORP (CHE) report earnings?
CHEMED CORP (CHE) will report earnings on 2026-04-21.
Can you provide the consensus estimates for CHEMED CORP next earnings?
The consensus EPS estimate for the next earnings of CHEMED CORP (CHE) is 5.57 USD and the consensus revenue estimate is 658.51M USD.
What is the expected long term growth rate for CHE stock?
The expected long term growth rate for CHEMED CORP (CHE) is 5.6%.